{
    "nct_id": "NCT00322153",
    "title": "A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Memantine in Patients With Moderate-to-Severe Dementia of the Alzheimer's Type",
    "status": "COMPLETED",
    "last_update_time": "2010-08-25",
    "description_brief": "The objective of this study is to evaluate the safety, tolerability, and efficacy of memantine compared to placebo in outpatients diagnosed with moderate-to-severe dementia of the Alzheimer's type on a concurrent acetylcholinesterase inhibitor (AChEI).",
    "description_detailed": "Memantine is a therapeutic agent that represents a unique class of Alzheimer's disease (AD) treatment options. A once daily (QD) dosing regimen in an AD population would simplify administration for the caregiver. The purpose of this study is to evaluate the safety and efficacy of modified release memantine taken once daily in outpatients with moderate-to-severe AD on a concurrent AChEI.",
    "phase": [
        "PHASE3"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "preAssignmentDetails": "Study consisted of 1-2 weeks single-blind placebo treatment followed by 24 weeks double-blind treatment. At the end of single-blind placebo treatment, patients meeting entry criteria were randomized (1:1) to 1 of 2 double-blind treatment groups receiving memantine or placebo.",
            "recruitmentDetails": "The recruitment period was from May 20, 2005 to April 18th, 2007 at 83 study centers in four countries (23 in Argentina, 11 in Chile, 11 in Mexico, and 38 in the US)",
            "groups": [
                {
                    "id": "FG000",
                    "title": "Placebo",
                    "description": "Matching placebo oral administration once daily for 24 weeks."
                },
                {
                    "id": "FG001",
                    "title": "Memantine ER",
                    "description": "28mg once daily oral administration for 24 weeks."
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "comment": "Randomized to placebo",
                                    "numSubjects": "335"
                                },
                                {
                                    "groupId": "FG001",
                                    "comment": "Randomized to Memantine ER",
                                    "numSubjects": "342"
                                }
                            ]
                        },
                        {
                            "type": "SAFETY POPULATION",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "comment": "Safety population defined as all patients who took at least one dose of double-blind study drug.",
                                    "numSubjects": "335"
                                },
                                {
                                    "groupId": "FG001",
                                    "comment": "Safety population: one patient was randomized but did not receive double-blind study drug.",
                                    "numSubjects": "341"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "272"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "273"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "63"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "69"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "21"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "34"
                                }
                            ]
                        },
                        {
                            "type": "Protocol Violation",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "14"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "18"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "10"
                                }
                            ]
                        },
                        {
                            "type": "Lack of Efficacy",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "8"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "3"
                                }
                            ]
                        },
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "4"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawn for other reasons",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "4"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Placebo",
                    "description": "Matching placebo oral administration once daily for 24 weeks."
                },
                {
                    "id": "BG001",
                    "title": "Memantine ER",
                    "description": "28mg once daily oral administration for 24 weeks."
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "335"
                        },
                        {
                            "groupId": "BG001",
                            "value": "341"
                        },
                        {
                            "groupId": "BG002",
                            "value": "676"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Customized",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "<= 64 years",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "26"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "34"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "60"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "65-74 years",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "79"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "85"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "164"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "75-84 years",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "179"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "176"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "355"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": ">= 85 years",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "51"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "46"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "97"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "76.8",
                                            "spread": "7.76"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "76.2",
                                            "spread": "8.35"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "76.5",
                                            "spread": "8.07"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "243"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "244"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "487"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "92"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "97"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "189"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "85"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "93"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "178"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Argentina",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "158"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "153"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "311"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Chile",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "44"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "46"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "90"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Mexico",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "48"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "49"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "97"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline in Severe Impairment Battery (SIB) at Week 24 (LOCF)",
                    "description": "The SIB was developed for the evaluation of cognitive function in patients with more advanced dementia, and evaluates the areas of memory, language, praxis, orientation, and attention. The SIB test items consist of simple, one-step commands presented with gestural cues that are repeated if necessary. The test contains 51 items, and the range of possible scores is 0 to 100 (with 0 being the worst result). The SIB has been shown to be a valid and reliable instrument sensitive to longitudinal change.",
                    "populationDescription": "Primary efficacy analysis was based on the Intent-to-Treat (ITT) Population. The ITT Population was consisted of all patients in the Safety Population who completed at least one post-Baseline efficacy assessment in SIB or CIBIC-Plus. The last-observation-carried-forward approach was used to impute missing post-Baseline values.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "Baseline to week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Matching placebo oral administration once daily for 24 weeks."
                        },
                        {
                            "id": "OG001",
                            "title": "Memantine ER",
                            "description": "28mg once daily oral administration for 24 weeks."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "327"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "332"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.4",
                                            "spread": "0.65"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.2",
                                            "spread": "0.65"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "The co-primary efficacy parameter was change from Baseline to Week 24 in SIB total score. Missing SIB total scores at Week 24 were imputed using the last-observation-carried-forward (LOCF) approach.",
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.001",
                            "statisticalMethod": "ANCOVA",
                            "statisticalComment": "Least-squares mean (-0.4 in placebo and 2.2 in memantine ER) are controlled for center and adjusted for SIB baseline value.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "2.6",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "1.0",
                            "ciUpperLimit": "4.2"
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Clinician's Interview-Based Impression of Change With Caregiver Input (CIBIC-plus) at Week 24 (LOCF)",
                    "description": "The CIBIC-Plus is a measure of an overall clinical effect and is based on a comprehensive evaluation at Baseline and later visits of four domains: general (overall clinical status), functional (including activities of daily living), cognitive, and behavioral. A skilled clinician interviews the patient, and includes information supplied by a knowledgeable caregiver. The CIBIC-Plus is a rating of the patient's global status relative to Baseline, ranging from a score of 1, indicating \"marked improvement\" to a score of 4, indicating \"no change\" to a score of 7, indicating \"marked worsening.\"",
                    "populationDescription": "Primary efficacy analysis was based on the Intent-to-Treat (ITT) Population. The ITT Population was consisted of all patients in the Safety Population who completed at least one post-Baseline efficacy assessment in SIB or CIBIC-Plus. The last-observation-carried-forward approach was used to impute missing post-Baseline values.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "Week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Matching placebo oral administration once daily for 24 weeks."
                        },
                        {
                            "id": "OG001",
                            "title": "Memantine ER",
                            "description": "28mg once daily oral administration for 24 weeks."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "328"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "333"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4.1",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3.8",
                                            "spread": "0.07"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "The co-primary efficacy parameter was CIBIC-Plus total score at week 24. Missing CIBIC-Plus total scores at Week 24 were imputed using the last-observation-carried-forward (LOCF) approach.",
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.008",
                            "statisticalMethod": "Cochran-Mantel-Haenszel"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change From Baseline in the 19-Item Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL19) Scale at Week 24 (LOCF)",
                    "description": "The ADCS-ADL19 modified inventory consists of 19 items used to measure the functional capabilities of patients with moderate to severe dementia. Each activity-of-daily-living (ADL) item comprises a series of hierarchical subquestions ranging from the highest level of independent performance to complete loss of ability to perform the ADL Inventory. The inventory is performed by interviewing a person in close contact with the patient and covers the most usual and consistent performance of the patient over the preceding 4 weeks. Response range is 0 (total disability) to 54 (total independence).",
                    "populationDescription": "The secondary efficacy analysis was based on the ITT Population. The last-observation-carried-forward approach was used to impute missing post-Baseline values.",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Units on a scale",
                    "timeFrame": "Baseline to week 24",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Placebo",
                            "description": "Matching placebo oral administration once daily for 24 weeks."
                        },
                        {
                            "id": "OG001",
                            "title": "Memantine ER",
                            "description": "28mg once daily oral administration for 24 weeks."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "328"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "331"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-1.7",
                                            "spread": "0.44"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.0",
                                            "spread": "0.44"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "groupDescription": "The secondary efficacy parameter was change from Baseline at Week 24 in the total score of the 19-Item Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory (ADCS-ADL19). Missing scores at week 24 were imputed using the last-observation-carried-forward (LOCF) approach.",
                            "testedNonInferiority": false,
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.177",
                            "statisticalMethod": "ANCOVA",
                            "statisticalComment": "Least-squares mean (-1.7 in placebo and -1.0 in memantine ER) are controlled for center and adjusted for ADCS-ADL19 baseline value.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.7",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.3",
                            "ciUpperLimit": "1.8"
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "Occurring on or after the date of the first dose of double-blind study medication and within 30 days of the date of last dose of double-blind study medication.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Placebo",
                    "description": "Matching placebo oral administration once daily for 24 weeks.",
                    "seriousNumAffected": 21,
                    "seriousNumAtRisk": 335,
                    "otherNumAffected": 70,
                    "otherNumAtRisk": 335
                },
                {
                    "id": "EG001",
                    "title": "Memantine ER",
                    "description": "28mg once daily oral administration for 24 weeks.",
                    "seriousNumAffected": 28,
                    "seriousNumAtRisk": 341,
                    "otherNumAffected": 67,
                    "otherNumAtRisk": 341
                }
            ],
            "seriousEvents": [
                {
                    "term": "Atrioventricular block complete",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Bradycardia",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Sinus bradycardia",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Cardiac Arrest",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Cardiac Failure Congestive",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Cardio-respiratory arrest",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Myocardial infarction",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Rectal Prolapse",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Toothache",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Vomiting",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Chest Pain",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "General physical health deterioration",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Drowning",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Pneumonia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Lobar Pneumonia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Meningitis bacterial",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Bacteraemia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Herpes zoster",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 5,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Pneumothorax traumatic",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Skin laceration",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Spinal compression fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Head Injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Hip fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Traumatic brain injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Anticoagulation drug level above therapeutic",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Anorexia",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Hypoglycaemia",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Hypokalaemia",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Back Pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Cholesteatoma",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Metastatic carcinoma of the bladder",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Renal neoplasm",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Prostate cancer",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Cerebrovascular accident",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Syncope",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 2,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Cerebral haemorrhage",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Dementia Alzheimer's type",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Facial paresis",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Ischaemic stroke",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Myoclonus",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Syncope vasovagal",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Transient ischaemic attack",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Convulsion",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Intracranial haematoma",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Anxiety disorder due to a general medical condition",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Delusion",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Renal failure",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Urinary retention",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Pneumonia aspiration",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Respiratory arrest",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Excessive skin",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Proctocolectomy",
                    "organSystem": "Surgical and medical procedures",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Deep vein thrombosis",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Hypotension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 341
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "notes": "Treatment emergent adverse event",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 26,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 19,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "notes": "Treatment emergent adverse event",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 24,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 19,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "notes": "Treatment emergent adverse event",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 17,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 19,
                            "numAtRisk": 341
                        }
                    ]
                },
                {
                    "term": "Diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 10.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "notes": "Treatment emergent adverse event",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 13,
                            "numAtRisk": 335
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 17,
                            "numAtRisk": 341
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "OTHER",
                "restrictiveAgreement": true,
                "otherDetails": "Sponsor can review results communications prior to public release \\& can embargo communications re: results for 90 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential info. Upon sponsor's request, PI shall delete any proprietary info \\& shall not include raw data in pub. On sponsor's request, PI shall delay submission for any pub while sponsor files patent apps. If trial is multi-center, PI agrees that first publication shall be a multi-center pub."
            },
            "pointOfContact": {
                "title": "Stephen M Graham, PhD",
                "organization": "Forest Research Institute",
                "email": "Stephen.Graham@frx.com",
                "phone": "201-427-8156"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "memantine"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The intervention is memantine, an oral small-molecule N-methyl-D-aspartate (NMDA) receptor antagonist used to reduce clinical deterioration in moderate-to-severe Alzheimer's disease; its mechanism is antiglutamatergic (symptomatic modulation of neurotransmission) rather than targeting amyloid or tau pathology. \ue200cite\ue202turn0search2\ue202turn0search7\ue201",
        "Act: Key extracted details from the trial description \u2014 drug: memantine (20 mg/day in standard trials), comparator: placebo, population: outpatients with moderate-to-severe Alzheimer's disease on a concurrent acetylcholinesterase inhibitor (AChEI). Memantine has shown benefit on cognition, function and global measures versus placebo in this population in randomized trials. \ue200cite\ue202turn0search2\ue202turn0search4\ue201",
        "Web search results (selected): NEJM randomized trial of memantine in moderate-to-severe AD showing clinical benefit versus placebo. \ue200cite\ue202turn0search2\ue201; Reviews/meta-analyses and clinical summaries describing memantine as an uncompetitive/moderate-affinity NMDA receptor antagonist indicated for moderate-to-severe AD. \ue200cite\ue202turn0search4\ue202turn0search5\ue201; Mechanism and therapeutic context summarized on AlzForum. \ue200cite\ue202turn0search7\ue201",
        "Reflect: The trial evaluates symptomatic safety/tolerability and efficacy (cognition/function/global) of memantine rather than a biologic or an anti-amyloid/tau disease-modifying approach. Therefore it fits the 'Cognitive enhancer' category (small-molecule symptomatic treatment). Note: memantine can also affect some behavioral symptoms, but the primary intent in this trial (moderate-to-severe AD cognitive/functional outcomes) supports the cognitive enhancer classification. \ue200cite\ue202turn0search2\ue202turn0search9\ue201"
    ],
    "agent_type": "D) Neurotransmitter Receptors",
    "explanation_agent": [
        "Reason: The trial tests memantine, an uncompetitive NMDA (glutamate) receptor antagonist that modulates excitatory neurotransmission (antiglutamatergic/symptomatic mechanism) rather than targeting amyloid, tau, or other disease-modifying pathways. \ue200cite\ue202turn0search1\ue202turn0search4\ue201",
        "Act: Extracted details \u2014 drug: memantine (oral, commonly 20 mg/day in pivotal trials); indication and demonstrated benefit: improved cognition/function vs placebo in moderate-to-severe AD in randomized trials (Reisberg et al., NEJM). These facts point to a neurotransmitter-receptor (glutamatergic/NMDA) target. \ue200cite\ue202turn0search0\ue202turn0search6\ue201",
        "Reflect: Classification as 'D) Neurotransmitter Receptors' aligns with CADRO because memantine acts on the NMDA glutamate receptor (a neurotransmitter receptor). The trial is symptomatic/cognitive-enhancer focused rather than disease-modifying, so other CADRO categories (e.g., A Amyloid beta, B Tau, F Inflammation) are not appropriate. No evidence in the description indicates multiple distinct biological targets requiring 'R) Multi-target' or a non-therapeutic focus requiring 'T) Other'. \ue200cite\ue202turn0search2\ue202turn0search5\ue201",
        "Web search results (selected): 1) Reisberg B. et al., \"Memantine in Moderate-to-Severe Alzheimer's Disease\", NEJM 2003 \u2014 randomized trial showing clinical benefit vs placebo. \ue200cite\ue202turn0search0\ue201 2) AlzForum summary: memantine = noncompetitive/low- to medium-affinity NMDA receptor antagonist. \ue200cite\ue202turn0search1\ue201 3) PubMed review of NMDA antagonists and memantine describing mechanism and indication. \ue200cite\ue202turn0search2\ue201 4) StatPearls (NCBI): clinical/pharmacologic summary of memantine as an NMDAR antagonist used in AD. \ue200cite\ue202turn0search4\ue201 5) NEJM (2012) and JAMA (pivotal) trial summaries of memantine in combination with cholinesterase inhibitors for moderate-to-severe AD. \ue200cite\ue202turn0search6\ue202turn0search3\ue201"
    ]
}